Calcium channel blockade limits transcriptional, translational and functional up-regulation of the cardiac calpain system after myocardial infarction

European Journal of Pharmacology

Volumn 453, Issue 1, 2002, Pages 99-109

  Sandmann, Steffen ^a   Spormann, Johannes ^a   Prenzel, Freerk ^a   Shaw, Lee ^a   Unger, Thomas ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Calpain system; Cardiac Ca2+ channel; Myocardial infarction

Indexed keywords

AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL T TYPE; CALPAIN; COLLAGEN; DYE; ISOENZYME; MESSENGER RNA; MIBEFRADIL; PICROSIRIUS RED; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART VENTRICLE HYPERTROPHY; MALE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; RAT; RNA TRANSLATION; STAINING; UPREGULATION;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CALPAIN; GENE EXPRESSION REGULATION; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; PROTEIN BIOSYNTHESIS; RATS; RATS, WISTAR; RNA, MESSENGER; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 0037131006     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02384-1     Document Type: Article

References (53)

1. Arthur G.D., Belcastro A.N. A calcium stimulated cysteine protease involved in isoproterenol induced cardiac hypertrophy. Mol. Cell. Biochem. 176:1997;241-248.
2. Bogdanov K.Y., Ziman B.D., Spurgeon H.A., Lakatta E.G. L- and T-type calcium currents differ in finch and rat ventricular cardiomyocytes. J. Mol. Cell. Cardiol. 27:1995;2581-2593.
3. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
4. Brilla C., Janicki J.S., Weber K.T. Impaired diastolic function and coronary reserve in genetic hypertension: role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries. Circ. Res. 69:1991;107-115.
5. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
6. Contard F., Koteliansky V., Marotte F., Dubud I., Rappaport L., Samuel J.L. Specific alterations in the distribution of extracellular matrix components within rat myocardium during the development of pressure overload. Lab. Invest. 64:1991;65-75.
7. Doumit M.E., Koohmaraie M. Immunoblot analysis of calpastatin degradation: evidence for cleavage by calpain in post mortem muscle. J. Anim. Sci. 77(6):1999;1467-1473.
8. 2+-dependent proteolysis. Circ. Res. 78:1996;455-465.
9. Gay R.G. Early and late effects of captopril treatment after large myocardial infarction in rats. JACC. 16(4):1990;967-977.
10. Hoff P.T., Tamura Y., Luchesi B.R. Cardioprotective effects of amlodipine in the ischemic-reperfused heart. Am. J. Cardiol. 64:1989;101I-116I.
11. Hong S.C., Goto Y., Lanzino G., Solea S., Kassell N.F., Lee K.S. Neuroprotection with a calpain inhibitor in a model of focal cerebral ischemia. Stroke. 25:1994;663-669.
12. Iwamoto H., Miura T., Okamura T., Shirakawa K., Iwatate M., Kawamura S., Tatsuno H., Ikeda Y., Matsuzaki M. Calpain inhibitor-1 reduces infarct size and DNA fragmentation of myocardium in ischemia/reperfusion rat heart. J. Cardiovasc. Pharmacol. 33:1999;580-586.
13. Janse M.J., Kleber A.G. Electrophysiological changes and ventricular arrhythmias in the early phase of regional myocardial ischemia. Circ. Res. 49:1981;1069-1081.
14. Katz A.M., Reuter H. Cellular calcium and cardiac cell death. Am. J. Cardiol. 44(1):1979;188-190.
15. Lampi K.J., Kadoya K., Azuma M., David L.L., Shearer T.R. Comparison of cell-permeable calpain inhibitors and E 64 in reduction of cataract in cultured rat lenses. Toxicol. Appl. Pharmacol. 117:1992;53-57.
16. Lory P., Rassendren F.A., Richard S., Tiaho F., Nargeot J. Characterization of voltage-dependent calcium channel expressed in Xenopus oocytes injected with mRNA from rat heart. J. Physiol. 429:1990;95-112.
17. 2+ handling in rats with chronic myocardial infarction. J. Pharmacol. Exp. Ther. 291(3):1999;1038-1044.
18. Mishra S.K., Hermsmeyer K. Selective inhibition of T-type calcium channels by RO 40-5967. Circ. Res. 75:1994;144-148.
19. Nayler W.G., Britnell S. Calcium antagonists and tissue protection. J. Cardiovasc. Pharmacol. 18(1):1991;S1-S5.
20. Nuss B.H., Houser S.R. T-type calcium current is expressed in hypertrophied adult feline left ventricular myocytes. Circ. Res. 73:1993;777-782.
21. 2+ channels. Biochem. Biophys. Res. Commun. 162:1989;448-455.
22. Pasquet J.M., Dachary-Prigent J., Nurden T. Calcium influx is a determining factor of calpain activation and microparticle formation in platelets. Eur. J. Biochem. 239:1996;647-654.
23. Passier R.C.J.J., Smits J.F.M., Verluyten M.J.A., Daemen M.J.A.P. Expression and localisation of renin and angiotensinogen in rat heart after myocardial infarction. Am. J. Physiol. 271:1996;H1040-H1048.
24. Permutt M.A., Bernal-Mizrachi E., Inoue H. Calpain 10: the first positional cloning of a gene for type 2 diabetes? J. Clin. Invest. 106:2000;819-821.
25. Pussard S., Cottin P., Brustis J.J., Talmat S., Elamrani N., Ducastaing A. Quantitative measurement if calpain I and II mRNAs in differentiating rat muscle cells using a competitive polymerase chain reaction method. Biochemistry. 75:1993;885-890.
26. Qin D., Jian P., Boutjdir M., El-Sherif N. Expression of T-type calcium channel current in remodeled hypertrophied left ventricle from adult rat following myocardial infarction. (Abstract) Circulation. 92(Suppl. I):1995;I587.
27. Rechsteiner M., Rogers S.W. PEST sequences and regulation by proteolysis. Trends Biochem. Sci. 21(7):1996;267-271.
28. Reddy P.A., Anandavalli T.E., Anandaraj M.P.J.S. Calcium activated neutral protease (milli- and microCNP) and endogenous CANP inhibitor of muscle in Duchenne muscular dystrophy (DMD). Clin. Chim. Acta. 160:1986;281-288.
29. Riede U., Reith A. Morphometry in Pathology. Research and Practice. vol. 166:1980;Gustav Fischer Verlag, Stuttgart. Nos. 2-3.
30. Saito K.I., Elce J.S., Hamos J.E., Nixon R.A. Widespread activation of calcium-activated neutral protease (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc. Natl. Acad. Sci. U. S. A. 90:1993;2628-2632.
31. Sandmann S., Spitznagel H., Chung O., Xia Q.G., Illner S., Jänichen G., Rossius B., Daemen M.J.A.P., Unger Th. Effects of the calcium channel antagonist mibefradil on haemodynamic and morphological parameters in myocardial infarction-induced cardiac failure in rats. Cardiovasc. Res. 39:1998;339-350.
32. 2+-handling in infarct-induced heart failure in rats. Cardiovasc. Res. 44:1999;67-80.
33. Sandmann S., Bohle R.M., Dreyer Th., Unger Th. The T-type calcium channel blocker mibefradil reduced interstitial and perivascular fibrosis and improved haemodynamic parameters in myocardial infarction-induced cardiac failure in rats. Virchows Arch. 436(2):2000;147-157.
34. Sandmann S., Claas R., Cleutjens J.P.M., Daemen M.J.A.P., Unger Th. Calcium channel blockade limits cardiac remodeling and improves cardiac function in myocardial infarction-induced heart failure in rats. J. Cardiovasc. Pharmacol. 37:2001;64-77.
35. Sandmann S., Yu M., Unger Th. Transcriptional and translational regulation of calpain in the rat heart after myocardial infarction - effects of AT1 and AT2 receptor antagonists and ACE inhibitor. Br. J. Pharmacol. 132:2001;767-777.
36. Sasaki T., Kikuchi T., Yumoto N., Yoshimura N., Murachi T. Comparative specificity and kinetic studies on porcine calpain I and calpain II with naturally occurring peptides and synthetic fluorogenic substrates. J. Biol. Chem. 259(20):1984;12489-12494.
37. Sawamura I., Hazama F., Kinoshita M. Histological and histometrical study of myocardial fibrosis in spontaneously hypertensive rats of the stroke-prone strain. Jpn. Circ. J. 54:1990;1274-1282.
38. 2+-channels are abnormal in genetically determined cardiomyopathic hamster hearts. Circ. Res. 75(1):1994;149-155.
39. Shimada T., Yoshiyama M., Takeuchi K., Omura T., Takemoto Y., Kim S., Iwao H., Yoshikawa J. Long acting calcium antagonist amlodipine prevents left ventricular remodeling after myocardial infarction in rats. Cardiovasc. Res. 37:1998;618-626.
40. 2+ influx. FEBS. 259:1989;1-4.
41. Sorimachi H., Saido T.C., Suzuki K. New era of calpain research. FEBS Lett. 343:1994;1-5.
42. Sorimachi Y., Harada K., Saido T.C., Ono T., Kawashima S., Yoshida K. Downregulation of calpastatin in rat heart after brief ischemia and reperfusion. J. Biochem. (Tokyo). 122(4):1997;743-748.
43. 2+-activated proteinases from hearts of hypertensive rats. Biochem. Biophys. Acta. 830:1985;258-266.
44. Steenbergen C., Murphy E., Levy L., London R.E. Elevation of cytosolic free calcium concentration early in myocardial ischemia in perfused rat heart. Circ. Res. 60:1987;700-707.
45. Steenbergen C., Murphy E., Watts J.A., London R.E. Correlation between cytosolic free calcium, contracture, ATP, and irreversible ischemic injury in perfused rat hearts. Circ. Res. 66:1990;135-146.
46. Suzuki K., Imajoh S., Emori Y., Kawasaki H., Minami Y., Ohno S. Calcium activated neutral protease and its endogenous inhibitor: activation at the cell membrane and biological function. FEBS Lett. 220:1987;271-277.
47. Tolnai S., Korecky B. Calcium-dependent proteolysis and its inhibition in the ischemic rat myocardium. Can. J. Cardiol. 2:1986;42-47.
48. 2+ sensitivity change and troponin loss in cardiac natural actomyosin after coronary occlusion. Am. J. Physiol. 240:1981;H704-H708.
49. ε proteolysis in reperfused ferret hearts. Cardiovasc. Res. 35:1997;60-67.
50. Wang K.K.W., Villalobo A., Roufogalis B.D. Calmodulin-binding proteins as calpain substrates. Biochem. J. 262:1989;693-706.
51. Weishaar R.E., Bing R.J. The beneficial effect of a calcium channel blocker, diltiazem, on the ischemic-reperfused heart. J. Mol. Cell. Cardiol. 12:1980;993-1009.
52. 2+] in mammalian ventricle: dynamic control by cellular process. Annu. Rev. Physiol. 52:1990;467-485.
53. Yoshida K., Yamasaki Y., Kawashima S. Calpain activity alters in rat myocardial subfractions after ischemia or reperfusion. Biochim. Biophys. Acta. 1182:1993;215-220.